Published in J Clin Invest on August 01, 2001
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev (2003) 3.48
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest (2001) 2.98
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med (2011) 2.21
NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell (2004) 2.14
Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve (2011) 2.00
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol (2015) 1.91
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS J (2010) 1.78
Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol (2004) 1.61
Heparan sulfate: lessons from knockout mice. J Clin Invest (2001) 1.56
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood (2007) 1.49
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc Natl Acad Sci U S A (2002) 1.49
Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One (2009) 1.46
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta (2009) 1.46
Significance of heparanase in cancer and inflammation. Cancer Microenviron (2011) 1.46
Electron detachment dissociation of dermatan sulfate oligosaccharides. J Am Soc Mass Spectrom (2007) 1.40
Influence of charge state and sodium cationization on the electron detachment dissociation and infrared multiphoton dissociation of glycosaminoglycan oligosaccharides. J Am Soc Mass Spectrom (2008) 1.40
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol (2007) 1.36
Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J Virol (2002) 1.33
The chemical neurobiology of carbohydrates. Chem Rev (2008) 1.33
Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival. Neoplasia (2006) 1.28
Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin Exp Metastasis (2007) 1.27
The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med (2007) 1.25
Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation. Tissue Eng Part A (2010) 1.24
A central function for perlecan in skeletal muscle and cardiovascular development. J Cell Biol (2008) 1.22
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biol (2010) 1.21
Tumorigenic and adhesive properties of heparanase. Semin Cancer Biol (2010) 1.10
Perlecan and tumor angiogenesis. J Histochem Cytochem (2003) 1.09
Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J (2002) 1.07
Heparan sulfate is an attachment factor for foamy virus entry. J Virol (2012) 1.07
Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J Biol Chem (2011) 1.04
Endothelial heparan sulfate in angiogenesis. Prog Mol Biol Transl Sci (2010) 1.02
Heparin impairs angiogenesis through inhibition of microRNA-10b. J Biol Chem (2011) 1.01
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biol (2009) 1.01
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion. Int J Biochem Cell Biol (2008) 1.01
Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med (2011) 1.00
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. Biochem J (2004) 1.00
Proteoglycans in prostate cancer. Nat Rev Urol (2012) 0.99
Role of heparan sulfate in sexually transmitted infections. Glycobiology (2012) 0.98
Extracellular matrix proteins and tumor angiogenesis. J Oncol (2010) 0.97
Heparan sulfate signaling in cancer. Trends Biochem Sci (2014) 0.97
Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J Biol Chem (2010) 0.96
The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts. BMC Dev Biol (2007) 0.96
The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues. Matrix Biol (2007) 0.93
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer. BMC Cancer (2013) 0.93
Heparanase regulates retention and proliferation of primitive Sca-1+/c-Kit+/Lin- cells via modulation of the bone marrow microenvironment. Blood (2008) 0.89
Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol (2002) 0.88
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer. J Exp Clin Cancer Res (2011) 0.87
Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. Leukemia (2011) 0.87
Proteomic profiling of endorepellin angiostatic activity on human endothelial cells. Proteome Sci (2008) 0.87
Endorepellin evokes autophagy in endothelial cells. J Biol Chem (2014) 0.86
Hallmarks of glycosylation in cancer. Oncotarget (2016) 0.86
Perlecan deficiency causes endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase. Physiol Rep (2015) 0.85
Colocalization in vivo and association in vitro of perlecan and elastin. Histochem Cell Biol (2011) 0.85
The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma. BMC Cancer (2009) 0.85
The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine. Oncotarget (2015) 0.84
WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling. J Biol Chem (2010) 0.83
Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans. J Biol Chem (2004) 0.83
Role of heparan sulfate in ocular diseases. Exp Eye Res (2013) 0.82
Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol (2008) 0.82
Interaction of platelet endothelial cell adhesion molecule (PECAM) with α2,6-sialylated glycan regulates its cell surface residency and anti-apoptotic role. J Biol Chem (2014) 0.81
MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J Biol Chem (2013) 0.81
The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle. Front Oncol (2015) 0.81
GAG-ID: Heparan Sulfate (HS) and Heparin Glycosaminoglycan High-Throughput Identification Software. Mol Cell Proteomics (2015) 0.81
Glycosaminoglycan secretion in xyloside treated polarized human colon carcinoma Caco-2 cells. Glycoconj J (2009) 0.80
Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. Pigment Cell Melanoma Res (2014) 0.80
A starting place for the road to function. Glycoconj J (2003) 0.80
Role of Filopodia in HSV-1 Entry into Zebrafish 3-O-Sulfotransferase-3-Expressing Cells. Open Virol J (2013) 0.80
Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry. Open Virol J (2013) 0.79
Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans. J Biol Chem (2011) 0.79
The association of arylendosulfatase 1 (SULF1) gene polymorphism with recurrent miscarriage. J Assist Reprod Genet (2013) 0.79
Roles of glycosaminoglycans and glycanmimetics in tumor progression and metastasis. Glycoconj J (2014) 0.79
Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions. Semin Cell Dev Biol (2009) 0.78
Endorepellin-evoked Autophagy Contributes to Angiostasis. J Biol Chem (2016) 0.78
Neonatal exposure to high doses of 17β-estradiol results in inhibition of heparanase-1 expression in the adult prostate. Histochem Cell Biol (2011) 0.77
Methylene blue inhibits angiogenesis in chick chorioallontoic membrane through a nitric oxide-independent mechanism. J Cell Mol Med (2006) 0.77
Microarray method for the rapid detection of glycosaminoglycan-protein interactions. Methods Mol Biol (2012) 0.77
Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases. Hippokratia (2009) 0.77
The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy. Connect Tissue Res (2015) 0.77
A current view of perlecan in physiology and pathology: A mosaic of functions. Matrix Biol (2016) 0.76
Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy. Cardiovasc Res (2016) 0.76
Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. FEBS J (2016) 0.76
Novel human-derived extracellular matrix induces in vitro and in vivo vascularization and inhibits fibrosis. Biomaterials (2015) 0.76
Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates. Metabolites (2012) 0.76
Angiopoietin-1 prevents severe bleeding complications induced by heparin-like drugs and fibroblast growth factor-2 in mice. Am J Physiol Heart Circ Physiol (2015) 0.76
Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma. J AIDS Clin Res (2014) 0.76
Smooth muscle specific deletion of Ndst1 leads to decreased vessel luminal area and no change in blood pressure in conscious mice. J Cardiovasc Transl Res (2012) 0.76
Extracellular Matrix, a Hard Player in Angiogenesis. Int J Mol Sci (2016) 0.75
Mechanisms of heparanase inhibitors in cancer therapy. Exp Hematol (2016) 0.75
3D co-culture model to analyze the crosstalk between endothelial and smooth muscle cells. Tissue Eng Part C Methods (2016) 0.75
Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer. Oncotarget (2016) 0.75
Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World J Gastroenterol (2014) 0.75
Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis. Int J Nanomedicine (2016) 0.75
A Multivariate Mixture Model to Estimate the Accuracy of Glycosaminoglycan Identifications Made by MS/MS and Database Search. Mol Cell Proteomics (2016) 0.75
The collαgen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles. PLoS One (2017) 0.75
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem (1998) 4.86
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature (2000) 3.90
Specificities of heparan sulphate proteoglycans in developmental processes. Nature (2000) 3.46
The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem (1996) 2.88
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med (1997) 2.33
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell (1994) 2.23
Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci U S A (2001) 2.19
Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development (2001) 1.96
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J (1994) 1.87
The elusive functions of proteoglycans: in vivo veritas. J Cell Biol (2000) 1.84
Fibroblast growth factor-2. Int J Biochem Cell Biol (2000) 1.80
Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem (2000) 1.75
Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res (2000) 1.70
Still more complexity in mammalian basement membranes. J Histochem Cytochem (2000) 1.57
Developmental expression of perlecan during murine embryogenesis. Dev Dyn (1997) 1.52
Cell surface glypicans are low-affinity endostatin receptors. Mol Cell (2001) 1.51
Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry (2000) 1.47
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest (1998) 1.46
Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol (2000) 1.43
Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J (1999) 1.38
Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. J Biol Chem (2001) 1.29
Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem (1999) 1.28
Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol (1994) 1.24
Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem (1991) 1.18
Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. Eur J Biochem (1998) 1.18
An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein. Mol Cell Neurosci (2001) 1.13
Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem (2000) 1.11
Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem (1997) 1.08
The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem (2000) 1.08
Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem (1999) 1.07
Transcriptional silencing of perlecan gene expression by interferon-gamma. J Biol Chem (1998) 1.05
A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. Cancer Res (1997) 1.05
Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct Funct (2000) 1.04
Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol Cell Biol (1997) 1.01
Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem (2000) 1.00
Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res (2001) 0.99
Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Ann Oncol (1997) 0.94
Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. Am J Pathol (1999) 0.92
Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan. Pathol Oncol Res (2000) 0.87
FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling. FASEB J (1999) 0.86
Molecular and structural mapping of collagen fibril interactions. Connect Tissue Res (2011) 1.48
Decorin binds near the C terminus of type I collagen. J Biol Chem (2000) 1.40
Collagen fibril surface displays a constellation of sites capable of promoting fibril assembly, stability, and hemostasis. Connect Tissue Res (2010) 1.14
Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation. Proc Natl Acad Sci U S A (1998) 1.12
Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J Biol Chem (2000) 1.06
Type I collagen and collagen mimetics as angiogenesis promoting superpolymers. Curr Pharm Des (2007) 0.98
Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood (2001) 0.95
Regulation of chondrogenesis by heparan sulfate and structurally related glycosaminoglycans. Dev Biol (1987) 0.91
Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J Biol Chem (2000) 0.90
Chondrogenesis of limb bud mesenchyme in vitro: stimulation by cations. Dev Biol (1986) 0.85
Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans. Thromb Haemost (2001) 0.81
Decreased serglycin proteoglycan size is associated with the platelet alpha granule storage defect in Wistar Furth hereditary macrothrombocytopenic rats. Serglycin binding affinity to type I collagen is unaltered. J Cell Physiol (1997) 0.77
Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair. J Vasc Res (2000) 0.77
Chondrogenic potential of chick embryonic calvaria: II. Matrix calcium may repress cartilage differentiation. Dev Dyn (1995) 0.76
Cisplatin-induced peptic ulcers, vagotomy, adrenal and calcium modulation. Anticancer Drugs (1994) 0.75
Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment. J Cell Physiol (2001) 0.75